PEACCEL ^Companies

The company offers an end-to-end solution for preclinical trials, identification of drug targets through dedicated artificial intelligence tools, evolutionary analysis of protein sequences, sequence divergence, ancestral gene reconstruction, protein structure analysis, and modeling and computational screening of mutant libraries, it offers the potential for significant competitive advantage to existing drug design platforms, enabling pharmaceutical companies to access previously inaccessible spaces to identify novel, life-changing morePeaccel- The AI company for Life Sciences - PitchBookpitchbook.com/profiles/company/500988-16